Subgroup analysis of clinical factors further revealed that the association between SDC1 expression in tumor cells and OS was particularly evident in patients aged 50 years or older, post-menopausal women, tumors ≤ 2 cm, and those with 0–3 nodal involvement. This evidence concerns the gene SDC1 and neoplasm.